Understanding immune responses to develop vaccines and therapies for infectious diseases
NIH Tetramer Core Facility
This study is all about learning how our immune system fights infections so we can create better vaccines and treatments, and it's designed to help researchers who are working on improving health for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11060159 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of how the immune system responds to infections, which is crucial for developing effective vaccines and treatments. The project supports the MHC Tetramer Core Facility, which synthesizes and distributes specialized reagents that help researchers study immune responses in detail. By providing these resources, the facility aims to facilitate advancements in public health and improve therapeutic strategies for infectious and immune-mediated diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by infectious diseases or those interested in vaccine development and immune response studies.
Not a fit: Patients with non-infectious diseases or those not involved in immune response research may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new vaccines and therapies that significantly improve prevention and treatment options for infectious diseases.
How similar studies have performed: Previous research has shown success in using similar approaches to enhance vaccine development and understanding of immune responses.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.